2017
DOI: 10.3201/eid2302.161210
|View full text |Cite
|
Sign up to set email alerts
|

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016

Abstract: In 2014, inactivated poliovirus vaccine (IPV) campaigns were implemented in Nigeria and Pakistan after clinical trials showed that IPV boosts intestinal immunity in children previously given oral poliovirus vaccine (OPV). We estimated the effect of these campaigns by using surveillance data collected during January 2014–April 2016. In Nigeria, campaigns with IPV and trivalent OPV (tOPV) substantially reduced the incidence of poliomyelitis caused by circulating serotype-2 vaccine–derived poliovirus (incidence r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 18 publications
1
14
0
Order By: Relevance
“…In agreement with reported mixed evidence about the benefit of past IPV use in endemic areas, this study finds a moderate effect of IPV use to date in Pakistan and Afghanistan on population immunity to WPV1 or cVDPV2 transmission compared to reliance on OPV‐only through 2017. The benefit comes primarily from the assumed effect of IPV boosting on intestinal immunity observed in clinical trials but further traces to our assumption that oropharyngeal transmission plays some role in overall poliovirus transmission and that IPV‐only can effectively limit oropharyngeal transmission .…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…In agreement with reported mixed evidence about the benefit of past IPV use in endemic areas, this study finds a moderate effect of IPV use to date in Pakistan and Afghanistan on population immunity to WPV1 or cVDPV2 transmission compared to reliance on OPV‐only through 2017. The benefit comes primarily from the assumed effect of IPV boosting on intestinal immunity observed in clinical trials but further traces to our assumption that oropharyngeal transmission plays some role in overall poliovirus transmission and that IPV‐only can effectively limit oropharyngeal transmission .…”
Section: Discussionsupporting
confidence: 90%
“…However, supply limitations forced the GPEI to delay IPV introduction in 20 countries and caused stock‐outs in other countries . Nevertheless, the GPEI prioritized IPV use in supplemental immunization activities (SIAs, i.e., campaigns that target children within a broad age range, typically through age four years, regardless of immunization history) based on evidence that IPV boosts the intestinal immunity of individuals with immunity from prior LPV (i.e., WPV, OPV, OPV‐related, and VDPV) infections, although modeling provided mixed evidence that this translates into a significant effect on transmission at the population level …”
Section: Introductionmentioning
confidence: 99%
“…iii. The issue of cVDPV (Circulating Vaccine Derived Polio Virus) should be effectively tackled as this poses significant risk to the successful elimination of the virus [35,36]. The synchronization of withdrawal of oral polio vaccine and the subsequent introduction of inactivated polio vaccine is pivotal to achieving this aim [37].…”
Section: Recommendations and Possible Way Outmentioning
confidence: 99%
“…Various mathematical and statistical models studied the poliovirus situation in Pakistan and Afghanistan to inform strategies to finish eradication in the two countries (Duintjer Tebbens et al., ; Mercer et al., ; Molodecky et al., ; Shirreff, Wadood, Vaz, Sutter, & Grassly, ). Immunization plans available as of late 2017 suggest no increase in the frequency of supplemental immunization activities (SIAs) in 2018 and 2019 compared to prior years, which implies insufficient intensity of efforts to interrupt WPV1 transmission unless the quality of activities substantially improves (Duintjer Tebbens et al., ; Kalkowska, Duintjer Tebbens, Pallansch, & Thompson, ).…”
Section: Introductionmentioning
confidence: 99%